Catalyst Pharmaceuticals, Inc.
CPRX
$20.17
-$0.45-2.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.64% | -0.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.64% | -0.28% | |||
| Cost of Revenue | 14.56% | -14.32% | |||
| Gross Profit | 1.65% | 2.79% | |||
| SG&A Expenses | -2.05% | 6.15% | |||
| Depreciation & Amortization | -0.01% | 0.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.83% | -1.17% | |||
| Operating Income | 4.63% | 0.83% | |||
| Income Before Tax | -2.80% | -3.90% | |||
| Income Tax Expenses | 18.12% | -20.26% | |||
| Earnings from Continuing Operations | -8.16% | 1.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.16% | 1.43% | |||
| EBIT | 4.63% | 0.83% | |||
| EBITDA | 4.02% | 0.73% | |||
| EPS Basic | -8.69% | 0.11% | |||
| Normalized Basic EPS | 4.64% | 0.43% | |||
| EPS Diluted | -8.89% | 2.67% | |||
| Normalized Diluted EPS | 4.76% | 1.20% | |||
| Average Basic Shares Outstanding | 0.57% | 1.32% | |||
| Average Diluted Shares Outstanding | 0.46% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||